U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06838624) titled 'RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis' on Feb. 17.
Brief Summary: The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are:
* Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients.
* Compare the outcomes of Redcord treatment with standard care practices.
Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, freque...